Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $40.94 million. The enterprise value is $67.00 million.
Important Dates
The next estimated earnings date is Monday, May 19, 2025, after market close.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 15.00 million shares outstanding. The number of shares has increased by 6.47% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 15.00M |
| Shares Change (YoY) | +6.47% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | 33.89% |
| Owned by Institutions (%) | 13.77% |
| Float | 7.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/TBV Ratio | 0.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.29 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.51 |
Financial Efficiency
Return on equity (ROE) is -25.45% and return on invested capital (ROIC) is -7.03%.
| Return on Equity (ROE) | -25.45% |
| Return on Assets (ROA) | -5.15% |
| Return on Invested Capital (ROIC) | -7.03% |
| Return on Capital Employed (ROCE) | -14.18% |
| Revenue Per Employee | $217,644 |
| Profits Per Employee | -$90,266 |
| Employee Count | 839 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, Zepp Health has paid $13.69 million in taxes.
| Income Tax | 13.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.71% in the last 52 weeks. The beta is 0.71, so Zepp Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -19.71% |
| 50-Day Moving Average | 2.88 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 49.90 |
| Average Volume (20 Days) | 22,803 |
Short Selling Information
| Short Interest | 4,887 |
| Short Previous Month | 2,672 |
| Short % of Shares Out | 0.57% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, Zepp Health had revenue of $182.60 million and -$75.73 million in losses. Loss per share was -$4.68.
| Revenue | 182.60M |
| Gross Profit | 70.23M |
| Operating Income | -47.25M |
| Pretax Income | -23.90M |
| Net Income | -75.73M |
| EBITDA | -39.79M |
| EBIT | -47.25M |
| Loss Per Share | -$4.68 |
Full Income StatementBalance Sheet
The company has $92.07 million in cash and $119.10 million in debt, giving a net cash position of -$27.04 million or -$1.80 per share.
| Cash & Cash Equivalents | 92.07M |
| Total Debt | 119.10M |
| Net Cash | -27.04M |
| Net Cash Per Share | -$1.80 |
| Equity (Book Value) | 252.73M |
| Book Value Per Share | 15.65 |
| Working Capital | 56.20M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 38.46%, with operating and profit margins of -25.88% and -41.47%.
| Gross Margin | 38.46% |
| Operating Margin | -25.88% |
| Pretax Margin | -34.02% |
| Profit Margin | -41.47% |
| EBITDA Margin | -21.79% |
| EBIT Margin | -25.88% |
| FCF Margin | n/a |